87 related articles for article (PubMed ID: 15829299)
81. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
Meyuhas R; Noy H; Montefiori DC; Denisova G; Gershoni JM; Gross G
Mol Immunol; 2005 May; 42(9):1099-109. PubMed ID: 15829299
[TBL] [Abstract][Full Text] [Related]
82. Janusin: new molecular design for bispecific reagents.
Traunecker A; Lanzavecchia A; Karjalainen K
Int J Cancer Suppl; 1992; 7():51-2. PubMed ID: 1428404
[TBL] [Abstract][Full Text] [Related]
83. [Analysis of the principal neutralization site of HIV-1 and vaccine research].
Okamoto Y; Honda M
Tanpakushitsu Kakusan Koso; 1997 May; 42(7 Suppl):1201-8. PubMed ID: 9170954
[No Abstract] [Full Text] [Related]
84. CD4 immunoadhesins in anti-HIV therapy: new developments.
Chamow SM; Duliege AM; Ammann A; Kahn JO; Allen JD; Eichberg JW; Byrn RA; Capon DJ; Ward RH; Ashkenazi A
Int J Cancer Suppl; 1992; 7():69-72. PubMed ID: 1428410
[TBL] [Abstract][Full Text] [Related]
85. Molecular makeup of HIV-1 envelope protein.
Veljkovic V; Veljkovic N; Metlas R
Int Rev Immunol; 2004; 23(5-6):383-411. PubMed ID: 15370272
[TBL] [Abstract][Full Text] [Related]
86. Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?
Riethmüller G; Deusch K; Sanders ME; Dalesandro MR; Kiefersauer S; Reiter C; Rieber EP
Immunol Ser; 1993; 59():261-9. PubMed ID: 8461391
[No Abstract] [Full Text] [Related]
87.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
